Back
Qiagen NV 10K Form
Buy
55
QGEN
Qiagen NV
Last Price:
$45.26
Seasonality Move:
7.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive QGEN News And Ratings
See the #1 stock for the next 7 days that we like better than QGEN
QGEN Financial Statistics
Sales & Book Value
| Annual Sales: | $2B |
|---|---|
| Cash Flow: | $138M |
| Price / Cash Flow: | 21.41 |
| Annual Sales: | $15.88 |
| Price / Book: | 2.83 |
Profitability
| EPS (TTM): | 0.40660 |
|---|---|
| Net Income (TTM): | $92.9M |
| Gross Margin: | $1.2B |
| Return on Equity: | 2.58% |
| Return on Assets: | 1.57% |
Qiagen NV Earnings Forecast
Key Qiagen NV Financial Ratios
-
The Gross Profit Margin over the past 29 years for QGEN is 62.77%.
-
The Selling, General & Administrative Expenses for QGEN have been equal to 29.47% of Gross Profit Margin.
-
The Research & Development expenses have been 10.10% of Revenue.
-
The Interest Expense is 15.65% of Operating Income.
-
The Net Earning history of QGEN is 17.37% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 18 years.
Qiagen NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | QGEN |
| CUSIP: | N72482 |
| Website: | qiagen.com |
Debt
| Debt-to-Equity Ratio: | 0.54 |
|---|---|
| Current Ratio: | 2.17 |
| Quick Ratio: | 1.62 |
Price-to-Earnings
| Trailing P/E Ratio: | 29.45 |
|---|---|
| Forward P/E Ratio: | 17.77 |